Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : HEB, Hemispherx Biopharma (AMEX)NEW -- Ignore unavailable to you. Want to Upgrade?

To: Graham Marshman who wrote (110)	12/2/1997 10:22:00 AM
From: F. Jay Abella, III	Read Replies (1) \| Respond to of 857

Graham: Just so you don't have to speculate, I will tell you here that I don't have a hidden agenda. Bluntly, I would like to know if the questions I raise can be answered by HEB at this time (without giving away confidential information). If the responses are cogent, absolute BS, or something in between, we will all be better able to understand whether Ampligen has a chance of ever getting FDA approval. That is my sole priority here, and I am using my prerogative to ask. I sincerely hope the company uses this as an opportunity to clarify some issues that I assure you, are not germane to only me. FJA